Harvard Bioscience Q1 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $21.77M Beat $19.20M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Harvard Bioscience (NASDAQ:HBIO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 150 percent decrease over earnings of $0.02 per share from the
Harvard Bioscience (NASDAQ:HBIO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 150 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $21.77 million which beat the analyst consensus estimate of $19.20 million by 13.41 percent. This is a 11.17 percent decrease over sales of $24.51 million the same period last year.